These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
402 related items for PubMed ID: 2984282
1. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis). Tosato G, Straus S, Henle W, Pike SE, Blaese RM. J Immunol; 1985 May; 134(5):3082-8. PubMed ID: 2984282 [Abstract] [Full Text] [Related]
2. Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis. Tosato G, Magrath I, Koski I, Dooley N, Blaese M. N Engl J Med; 1979 Nov 22; 301(21):1133-7. PubMed ID: 226884 [Abstract] [Full Text] [Related]
3. T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals. Tosato G, Magrath IT, Blaese RM. J Immunol; 1982 Feb 22; 128(2):575-9. PubMed ID: 6274959 [Abstract] [Full Text] [Related]
4. Regulatory T cell activity in primary and persistent Epstein-Barr virus infection. Wingate PJ, McAulay KA, Anthony IC, Crawford DH. J Med Virol; 2009 May 22; 81(5):870-7. PubMed ID: 19319950 [Abstract] [Full Text] [Related]
5. Suppressor T cell clones from patients with acute Epstein-Barr virus-induced infectious mononucleosis. Wang F, Blaese RM, Zoon KC, Tosato G. J Clin Invest; 1987 Jan 22; 79(1):7-14. PubMed ID: 3025263 [Abstract] [Full Text] [Related]
6. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis. Borysiewicz LK, Haworth SJ, Cohen J, Mundin J, Rickinson A, Sissons JG. Q J Med; 1986 Feb 22; 58(226):111-21. PubMed ID: 3012622 [Abstract] [Full Text] [Related]
7. Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection. Sugaya N, Kimura H, Hara S, Hoshino Y, Kojima S, Morishima T, Tsurumi T, Kuzushima K. J Infect Dis; 2004 Sep 01; 190(5):985-8. PubMed ID: 15295706 [Abstract] [Full Text] [Related]
8. CD8 lymphocytes during Epstein Barr virus (EBV) infection: A CD29 positive population is expanded in acute infectious mononucleosis. de Paoli P, Gennari D, Reitano M, Martelli P, Sacilotto C, Comoretto R, Santini G. Allergol Immunopathol (Madr); 1991 Sep 01; 19(2):95-7. PubMed ID: 1722959 [Abstract] [Full Text] [Related]
9. The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cell. Thorley-Lawson DA. J Immunol; 1980 Feb 01; 124(2):745-51. PubMed ID: 6243331 [Abstract] [Full Text] [Related]
10. B-cell polyclonal activation and Epstein-Barr viral abortive lytic cycle are two key features in acute infectious mononucleosis. Al Tabaa Y, Tuaillon E, Jeziorski E, Ouedraogo DE, Bolloré K, Rubbo PA, Foulongne V, Rodière M, Vendrell JP. J Clin Virol; 2011 Sep 01; 52(1):33-7. PubMed ID: 21684200 [Abstract] [Full Text] [Related]
11. Cell-mediated immunity to Epstein-Barr-virus-transformed lymphoblastoid cells in acute infectious mononucleosis. Royston I, Sullivan JL, Periman PO, Perlin E. N Engl J Med; 1975 Dec 04; 293(23):1159-63. PubMed ID: 171568 [Abstract] [Full Text] [Related]
12. T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosis. Klein E, Ernberg I, Masucci MG, Szigeti R, Wu YT, Masucci G, Svedmyr E. Cancer Res; 1981 Nov 04; 41(11 Pt 1):4210-5. PubMed ID: 6272964 [Abstract] [Full Text] [Related]
13. Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus. Tsokos GC, Magrath IT, Balow JE. J Immunol; 1983 Oct 04; 131(4):1797-801. PubMed ID: 6311898 [Abstract] [Full Text] [Related]
14. Infectious mononucleosis, Epstein-Barr virus, and chronic fatigue syndrome: a prospective case series. Fark AR. J Fam Pract; 1991 Feb 04; 32(2):202, 205-6, 209. PubMed ID: 1846641 [Abstract] [Full Text] [Related]
15. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells. Wasik M, Myc A, Matej H, Rudzka L. Arch Immunol Ther Exp (Warsz); 1983 Feb 04; 31(6):871-8. PubMed ID: 6331340 [Abstract] [Full Text] [Related]
16. Immunoregulatory functions of cultured human T lymphocytes. Uchiyama T, Broder S, Bonnard GD, Waldmann TA. Trans Assoc Am Physicians; 1980 Feb 04; 93():251-62. PubMed ID: 6264658 [Abstract] [Full Text] [Related]
17. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus. Yarchoan R, Redfield RR, Broder S. J Clin Invest; 1986 Aug 04; 78(2):439-47. PubMed ID: 3016028 [Abstract] [Full Text] [Related]
18. [Virological and immunological studies on inapparent Epstein-Barr virus infection in healthy individuals: in comparison to immunosuppressed patients and patients with infectious mononucleosis]. Imai S. Hokkaido Igaku Zasshi; 1990 Sep 04; 65(5):481-92. PubMed ID: 2172132 [Abstract] [Full Text] [Related]
19. Blastogenic response of purified human T-lymphocyte populations to Epstein-Barr virus (EBV). Gergely P, Ernberg I, Klein G, Steinitz M. Clin Exp Immunol; 1977 Dec 04; 30(3):347-53. PubMed ID: 203426 [Abstract] [Full Text] [Related]
20. CD4(+) T-cell responses to Epstein-Barr virus (EBV) latent membrane protein 1 in infectious mononucleosis and EBV-associated non-Hodgkin lymphoma: Th1 in active disease but Tr1 in remission. Marshall NA, Culligan DJ, Johnston PW, Millar C, Barker RN, Vickers MA. Br J Haematol; 2007 Oct 04; 139(1):81-9. PubMed ID: 17854310 [Abstract] [Full Text] [Related] Page: [Next] [New Search]